Soligenix Says Its Covid Vaccine Candidate Shows Broad Neutralizing Activity

Soligenix, Inc. (SNGX) on Tuesday said its vaccine candidate CiVax showed efficacy and broad neutralizing activity against SARS-coV-2 original strain as well as variants of concern including Beta, Gama and Delta, in non-human primates.

The article titled "Protein Vaccine Induces a Durable, More Broadly Neutralizing Antibody Response in Macaques than Natural Infection with SARS-CoV-2 P.1," which published the data from the pre clinical study of CiVax, has been posted as an accelerated preprint on bioRxiv, Soligenix said .

"The CiVax vaccine has demonstrated broad and robust immune responses in mice, which is recapitulated here in non-human primates and further shown to yield protection against infection with COVID-19 variants of concern," the company said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Bobo's recalled one lot of Bobo's 4-pack Almond Butter Protein Bars for potentially containing undeclared peanuts, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated after it was discovered that product containing peanuts was distributed in packaging that did not reveal the presence of peanuts on the ingredient deck. Birmingham, Michigan-based RFA Brands LLC, d/b/a myCharge is recalling about 67,000 units of myCharge powerbanks citing fire and burn risks, the U.S. Consumer Product Safety Commission said. The recall was initiated after myCharge received 30 reports of the powerbanks overheating, resulting in seven injuries as well as property damage to household flooring, walls and furniture. Comcast Corp. (CMCSA, CMCSK) on Thursday reported that profit for the third quarter doubled from last year, driven by 19 percent revenue growth amid significant growth across each of its businesses. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend.
Follow RTT